Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways
Part of paid clinical trials in Orangeburg, New York.
- Sponsor
- Nathan Kline Institute for Psychiatric Research
- Study ID
- NCT07469384
- Status
- Recruiting
Conditions
- SCHIZOPHRENIA 1 (Disorder)
- Schizo Affective Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Not accepted
Interventions
- transcranial direct current stimulation — DEVICEtDCS will be applied over cortical region MT+
- Sham stimulation — DEVICERamp up/ramp down to simulate scalp sensation associated with tDCS. No sustained current flow
Study Details
This study investigates the ability of transcranial direct current stimulation (tDCS) applied over the motion processing area of the brain (area MT) to improve face emotion recognition (FER) ability. tDCS is a type of non-invasive brain stimulation in which low level currents are applied over the scalp to influence underlying brain function. In schizophrenia, impaired ability to detect facial motion has been shown to contribute to impaired FER, which, in turn, leads to difficulties in social cognition and poor social outcome. The study will use both fMRI and EEG to measure brain function while participants view moving dot and dynamic face stimuli. Analyses will compare changes in fMRI and EEG activity in individuals receiving active vs. sham stimulation.
Key Dates
- Start date
- Feb 1, 2026
- Status verified
- Mar 2026
- Primary completion
- Apr 30, 2030
- Completion
- Jul 31, 2030
Study Design
- Enrollment
- 120 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Active tDCSPersonalized, high-definition tDCS applied to area MT+
- Sham Comparator: Sham tDCSSham tDCS applied over area MT+, using ramp up/ramp down to simulate active treatment
Primary Outcome Measure
MT+ activation as determined using fMRI [ Time Frame: Simultaneously with the administration of the active or sham tDCS intervention during study day 10 ]
Central Contacts
- Odeta Beggel, MA845-398-2897
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Nathan Kline Institute | Orangeburg | New York | 10962 | Daniel C Javitt, MD, PhD (PRINCIPAL_INVESTIGATOR) Antigona Martinez, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Orangeburg, NY
Related Studies
- iTBS to Enhance Social Cognition in People With PsychosisRecruiting · Northwell Health · Glen Oaks, New York
- Visual Perception in SchizophreniaRecruiting · University of Rochester · Rochester, New York
- A PET/MRI Study of Cobenfy on Dopamine Transmission in SchizophreniaPHASE1/PHASE2 · Not Yet Recruiting · New York State Psychiatric Institute · New York, New York
- Cromoglicate Adjunctive Therapy for Outpatients With SchizophreniaPHASE1/PHASE2 · Recruiting · Vishwajit Nimgaonkar, MD PhD · Pittsburgh, Pennsylvania